Patents by Inventor Roman Urfer

Roman Urfer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human trk receptors and neurotrophic factor inhibitors
    Publication number: 20020146416
    Abstract: The invention concerns human trkB and trkC receptors and their functional derivatives. The invention further concerns immunoadhesins comprising trk receptor sequences fused to immunoglobulin sequences.
    Type: Application
    Filed: September 27, 2001
    Publication date: October 10, 2002
    Inventors: Leonard G. Presta, David L. Shelton, Roman Urfer
  • Nucleic acids encoding NGF variants
    Patent number: 6365373
    Abstract: NGF variants which have trkC-binding activity and trkC-signal inducing activity are provided. The variants optionally have trkA or trkB binding and signal induction activity. The NGF variants of the present invention are useful in the treatment of neuronal disorders. Nucleic acids and expression vectors encoding the NGF variant neurotrophins are also provided.
    Type: Grant
    Filed: April 24, 1998
    Date of Patent: April 2, 2002
    Assignee: Genentech, Inc.
    Inventors: Leonard G. Presta, Roman Urfer, John W. Winslow
  • NGF variants
    Patent number: 6333310
    Abstract: NGF variants which have trkC-binding activity and trkC-signal inducing activity are provided. The variants optionally have trkA or trkB binding and signal induction activity. The NGF variants of the present invention are useful in the treatment of neuronal disorders. Nucleic acids and expression vectors encoding the NGF variant neurotrophins are also provided.
    Type: Grant
    Filed: April 25, 1997
    Date of Patent: December 25, 2001
    Assignee: Genentech, Inc.
    Inventors: Leonard G. Presta, Roman Urfer, John W. Winslow
  • NGF VARIANTS
    Publication number: 20010012625
    Abstract: NGF variants which have trkC-binding activity and trkC-signal inducing activity are provided. The variants optionally have trkA or trkB binding and signal induction activity. The NGF variants of the present invention are useful in the treatment of neuronal disorders. Nucleic acids and expression vectors encoding the NGF variant neurotrophins are also provided.
    Type: Application
    Filed: April 24, 1998
    Publication date: August 9, 2001
    Inventors: LEONARD G. PRESTA, ROMAN URFER, JOHN W. WINSLOW
  • Human trk receptors and neurotrophic factor inhibitors
    Patent number: 6027927
    Abstract: The invention concerns human trkB and trkC receptors and their functional derivatives. The invention further concerns immunoadhesins comprising trk receptor sequences fused to immunoglobin sequences.
    Type: Grant
    Filed: October 1, 1997
    Date of Patent: February 22, 2000
    Assignee: Genentech, Inc.
    Inventors: Leonard G. Presta, David L. Shelton, Roman Urfer
  • Human trk receptors and neurotrophic factor inhibitors
    Patent number: 6025166
    Abstract: The invention concerns human trkB and trkC receptors and their functional derivatives. The invention further concerns imnunoadhesins comprising trk receptor sequences fused to immunoglobulin sequences.
    Type: Grant
    Filed: May 19, 1995
    Date of Patent: February 15, 2000
    Assignee: Genentech, Inc.
    Inventors: Leonard G. Presta, David L. Shelton, Roman Urfer
  • Pantropic neurotrophic factors
    Patent number: 5981480
    Abstract: Pantropic neurotrophic factors which have multiple neurotrophic specificities are provided. The pantropic neurotrophic factors of the present invention are useful in the treatment of neuronal disorders. Nucleic acids and expression vectors encoding the pantropic neurotrophins are also provided.
    Type: Grant
    Filed: May 15, 1995
    Date of Patent: November 9, 1999
    Assignee: Genentech, Inc.
    Inventors: Roman Urfer, Leonard G. Presta, John W. Winslow
  • Human trk receptors and neurotrophic factor inhibitors
    Patent number: 5910574
    Abstract: The invention concerns human trkB and trkC receptors and their functional derivatives. The invention further concerns immunoadhesins comprising trk receptor sequences fused to immunoglobulin sequences.
    Type: Grant
    Filed: May 31, 1995
    Date of Patent: June 8, 1999
    Assignee: Genentech, Inc.
    Inventors: Leonard G. Presta, David L. Shelton, Roman Urfer
  • Human trk receptors and neurotrophic factor inhibitors
    Patent number: 5877016
    Abstract: The invention concerns human trkB and trkC receptors and their functional derivatives. The invention further concerns inmunoadhesins comprising trk receptor sequences fused to immunoglobulin sequences.
    Type: Grant
    Filed: August 5, 1994
    Date of Patent: March 2, 1999
    Assignee: Genentech, Inc.
    Inventors: Leonard G. Presta, David L. Shelton, Roman Urfer
  • Human TRK receptors and neurotrophic factor inhibitors
    Patent number: 5844092
    Abstract: The invention concerns human trkB and trkC receptors and their functional derivatives. The invention further concerns immunoadhesins comprising trk receptor sequences fused to immunoglobulin sequences.
    Type: Grant
    Filed: December 20, 1994
    Date of Patent: December 1, 1998
    Assignee: Genentech, Inc.
    Inventors: Leonard G. Presta, David L. Shelton, Roman Urfer
  • Pantropic neurotrophic factors
    Patent number: 5728803
    Abstract: Pantropic neurotrophic factors which have multiple neurotrophic specificities are provided. The pantropic neurotrophic factors of the present invention are useful in the treatment of neuronal disorders. Nucleic acids and expression vectors encoding the pantropic neurotrophins are also provided.
    Type: Grant
    Filed: May 12, 1995
    Date of Patent: March 17, 1998
    Assignee: Genentech, Inc.
    Inventors: Roman Urfer, Leonard G. Presta, John W. Winslow